BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28367341)

  • 61. Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
    Kedar PS; Harigae H; Ito E; Muramatsu H; Kojima S; Okuno Y; Fujiwara T; Dongerdiye R; Warang PP; Madkaikar MR
    Int J Hematol; 2019 Nov; 110(5):618-626. PubMed ID: 31401766
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Other erythrocyte enzyme deficiencies associated with non-haematological symptoms: phosphoglycerate kinase and phosphofructokinase deficiency.
    Fujii H; Miwa S
    Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):141-8. PubMed ID: 10916683
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Unexpectedly high but still asymptomatic iron overload in a patient with pyruvate kinase deficiency.
    Andersen FD; d'Amore F; Nielsen FC; van Solinge W; Jensen F; Jensen PD
    Hematol J; 2004; 5(6):543-5. PubMed ID: 15570302
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Splenectomy in the treatment of hemolytic anemia.
    Coon WW
    Arch Surg; 1985 May; 120(5):625-8. PubMed ID: 3985801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency.
    Chou R; DeLoughery TG
    Am J Hematol; 2001 Jul; 67(3):197-9. PubMed ID: 11391719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A case report of concomitant paroxysmal nocturnal hemoglobinuria and heterozygous β-thalassemia.
    Yin XL; Zhou TH; Peng L; Zhang XH; Wang L; Zhou YL; Chen YS; He YY
    Ann Hematol; 2011 Mar; 90(3):355-6. PubMed ID: 20556389
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Reduced deformability of erythrocytes as a common denominator of hemolytic anemias].
    Tillmann W
    Wien Med Wochenschr; 1986; 136 Spec No():14-6. PubMed ID: 3548086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Abnormal red blood cell morphological changes in thalassaemia associated with iron overload and oxidative stress.
    Chaichompoo P; Qillah A; Sirankapracha P; Kaewchuchuen J; Rimthong P; Paiboonsukwong K; Fucharoen S; Svasti S; Worawichawong S
    J Clin Pathol; 2019 Aug; 72(8):520-524. PubMed ID: 31010830
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PK-LR gene mutations in pyruvate kinase deficient Portuguese patients.
    Manco L; Ribeiro ML; Almeida H; Freitas O; Abade A; Tamagnini G
    Br J Haematol; 1999 Jun; 105(3):591-5. PubMed ID: 10354117
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hereditary spherocytosis and hemochromatosis.
    Brandenberg JB; Demarmels Biasiutti F; Lutz HU; Wuillemin WA
    Ann Hematol; 2002 Apr; 81(4):202-9. PubMed ID: 11976822
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Neonatal expression of beta-thalassemia trait associated with hereditary spherocytosis in two monozygotic twins].
    Ben Hamouda H; Mahjoub B; Soua H; Laradi S; Miled A; Sfar MT
    Arch Pediatr; 2017 Feb; 24(2):126-130. PubMed ID: 27979672
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
    Ricchi P; Meloni A; Costantini S; Spasiano A; Di Matola T; Pepe A; Cinque P; Filosa A
    Ann Hematol; 2017 Sep; 96(9):1541-1546. PubMed ID: 28707012
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does Profile of Hemoglobin Eβ-thalassemia Patients Change After Splenectomy? Experience of a Tertiary Thalassemia Care Centre in Eastern India.
    Mandal PK; Ghosh MK; Bhattacharyya M
    Indian J Hematol Blood Transfus; 2015 Dec; 31(4):446-52. PubMed ID: 26306069
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Beta thalassemia: molecular pathogenesis and clinical variability].
    Kulozik AE
    Klin Padiatr; 1991; 203(4):276-83. PubMed ID: 1942934
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inherited hemolytic anemia: a possessive beginner's guide.
    Mohandas N
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):377-381. PubMed ID: 30504335
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.
    Hilgard P; Gerken G
    World J Gastroenterol; 2005 Feb; 11(8):1241-4. PubMed ID: 15754414
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Late diagnosis of a rare disease.
    Hossainy NM
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21686831
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased Red Cell KCNN4 Activity in Sporadic Hereditary Xerocytosis Associated With Enhanced Single Channel Pressure Sensitivity of PIEZO1 Mutant V598M.
    Gnanasambandam R; Rivera A; Vandorpe DH; Shmukler BE; Brugnara C; Snyder LM; Andolfo I; Iolascon A; Silveira PA; Hamerschlak N; Gottlieb P; Alper SL
    Hemasphere; 2018 Oct; 2(5):e55. PubMed ID: 30887001
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fetal Pyruvate Kinase Deficiency Identified Incidentally in a Chinese Family at Risk for α-Thalassemia.
    Han J; Li J; Li DZ
    Indian J Hematol Blood Transfus; 2022 Apr; 38(2):424-426. PubMed ID: 35496968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.